These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38733307)

  • 1. Proportion of inflammatory bowel diseases patients with suboptimal disease control in daily clinical practice-Real-world evidence from the inflammatory bowel diseases-podcast study.
    D'Amico F; Gomollón F; Bamias G; Magro F; Targownik L; Leitner C; Heatta-Speicher T; Michelena N; Kolterer S; Lapthorn J; Kauffman L; Dignass A;
    United European Gastroenterol J; 2024 May; ():. PubMed ID: 38733307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IBD-PODCAST Spain: A Close Look at Current Daily Clinical Practice in IBD Management.
    Vega P; Huguet JM; Gómez E; Rubio S; Suarez P; Vera MI; Paredes JM; Hernández-Camba A; Plaza R; Mañosa M; Pajares R; Sicilia B; Madero L; Kolterer S; Leitner C; Heatta-Speicher T; Michelena N; Santos de Lamadrid R; Dignass A; Gomollón F
    Dig Dis Sci; 2024 Mar; 69(3):749-765. PubMed ID: 38217680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Suboptimal Disease Control on Patient Quality of Life: Real-World Data from the Observational IBD-PODCAST Canada Trial.
    Siffledeen J; Singh S; Shulman SM; Igoe J; Heatta-Speicher T; Leitner C; Chung CH; Targownik L
    Dig Dis Sci; 2024 May; 69(5):1636-1648. PubMed ID: 38493273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated Crohn's Colitis: Is Localization Crucial? Characteristics of Pediatric Patients From the CEDATA-GPGE Registry.
    Elonen L; Wölfle L; de Laffolie J; Posovszky C;
    Front Pediatr; 2022; 10():875938. PubMed ID: 35712614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world treatment patterns and disease control over one year in patients with inflammatory bowel disease in Brazil.
    Sassaki LY; Miszputen SJ; Kaiser Junior RL; Catapani WR; Bafutto M; Scotton AS; Zaltman C; Baima JP; Ramos HS; Faria MAG; Gonçalves CD; Guimaraes IM; Flores C; Amarante HMBS; Nones RB; Parente JML; Lima MM; Chebli JM; Ferrari MLA; Campos JF; Sanna MGP; Ramos O; Parra RS; da Rocha JJR; Feres O; Feitosa MR; Caratin RF; Senra JT; Santana GO
    World J Gastroenterol; 2021 Jun; 27(23):3396-3412. PubMed ID: 34163120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-World Persistence of Ustekinumab in the Treatment of Inflammatory Bowel Disease.
    Bressler B; Jones J; In TSH; Lan T; Iconaru C; Marshall JK
    Adv Ther; 2023 Oct; 40(10):4421-4439. PubMed ID: 37507652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.
    Sinopoulou V; Gordon M; Akobeng AK; Gasparetto M; Sammaan M; Vasiliou J; Dovey TM
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013531. PubMed ID: 34844288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
    Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MYTHS of
    James SD; Hawkins AT; Um JW; Ballard BR; Smoot DT; M'Koma AE
    Jpn J Gastroenterol Hepatol; 2020; 3(2):. PubMed ID: 37584007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological, Clinical, Patient-Reported and Economic Burden of Inflammatory Bowel Disease (Ulcerative colitis and Crohn's disease) in Spain: A Systematic Review.
    Barreiro-de Acosta M; Molero A; Artime E; Díaz-Cerezo S; Lizán L; de Paz HD; Martín-Arranz MD
    Adv Ther; 2023 May; 40(5):1975-2014. PubMed ID: 36928496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in incidence and clinical features of inflammatory bowel disease in Cardiff, UK over 50 years: an update for 2005-2016.
    Arms-Williams B; Hawthorne AB; Cannings-John R; Berry A; Harborne P; Trivedi A
    Scand J Gastroenterol; 2023 Jun; 58(6):619-626. PubMed ID: 36562277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Safety, Medical Resource Utilization, and Treatment Costs by Drug Class for Management of Inflammatory Bowel Disease in the United States Based on Insurance Claims Data.
    Long GH; Tatro AR; Oh YS; Reddy SR; Ananthakrishnan AN
    Adv Ther; 2019 Nov; 36(11):3079-3095. PubMed ID: 31562607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations.
    Le Berre C; Loy L; Lönnfors S; Avedano L; Piovani D
    World J Gastroenterol; 2020 Aug; 26(29):4343-4355. PubMed ID: 32848338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sleep disturbance and risk of active disease in patients with Crohn's disease and ulcerative colitis.
    Ananthakrishnan AN; Long MD; Martin CF; Sandler RS; Kappelman MD
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):965-71. PubMed ID: 23376797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etrolizumab for the Treatment of Ulcerative Colitis and Crohn's Disease: An Overview of the Phase 3 Clinical Program.
    Sandborn WJ; Vermeire S; Tyrrell H; Hassanali A; Lacey S; Tole S; Tatro AR;
    Adv Ther; 2020 Jul; 37(7):3417-3431. PubMed ID: 32445184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of Crohn's disease in children after total colectomy for ulcerative colitis.
    Mortellaro VE; Green J; Islam S; Bass JA; Fike FB; St Peter SD
    J Surg Res; 2011 Sep; 170(1):38-40. PubMed ID: 21470637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.